|
|
GEO help: Mouse over screen elements for information. |
|
Status |
Public on Jul 31, 2024 |
Title |
AS01-adjuvanted vaccine promotes functional and epigenetic modifications in monocytes [scATAC-seq] |
Organism |
Homo sapiens |
Experiment type |
Genome binding/occupancy profiling by high throughput sequencing
|
Summary |
HBS/AS01 adjuvanted vaccine induces changes in the chromatin structure in monocyte population impacting their gene expression, an effect that lasts until 6 months post vaccination
|
|
|
Overall design |
frozen PBMCS isolated at D32, D44, D60, D180 post dose 2 after HBS/AS01 vaccination were depleted from CD3+ cells and processed via single cell ATACseq
*************************************************************** Submitter states that missing raw files are due to patient privacy concerns. ***************************************************************
|
|
|
Contributor(s) |
Bechtold V, Essaghir A, Scaillet A, Tilman S, Bozzetti B |
Citation missing |
Has this study been published? Please login to update or notify GEO. |
|
Submission date |
Oct 06, 2023 |
Last update date |
Jul 31, 2024 |
Contact name |
Viviane Jeanne Bechtold |
E-mail(s) |
viviane.x.bechtold@gsk.com
|
Organization name |
GSK
|
Department |
Molecular Biology
|
Lab |
Vaccinomics
|
Street address |
rue de l'Institut 89
|
City |
Rixensart |
State/province |
Brabant Wallon |
ZIP/Postal code |
1330 |
Country |
Belgium |
|
|
Platforms (1) |
GPL24676 |
Illumina NovaSeq 6000 (Homo sapiens) |
|
Samples (31)
|
GSM7829741 |
CD3+ depleted, epigenetic: ATAC, D0, S3 |
GSM7829742 |
CD3+ depleted, epigenetic: ATAC, D180, S3 |
GSM7829743 |
CD3+ depleted, epigenetic: ATAC, D32, S3 |
GSM7829744 |
CD3+ depleted, epigenetic: ATAC, D44, S3 |
GSM7829745 |
CD3+ depleted, epigenetic: ATAC, D0, S7 |
GSM7829746 |
CD3+ depleted, epigenetic: ATAC, D180, S7 |
GSM7829747 |
CD3+ depleted, epigenetic: ATAC, D32, S7 |
GSM7829748 |
CD3+ depleted, epigenetic: ATAC, D44, S7 |
GSM7829749 |
CD3+ depleted, epigenetic: ATAC, D0, S8 |
GSM7829750 |
CD3+ depleted, epigenetic: ATAC, D180, S8 |
GSM7829751 |
CD3+ depleted, epigenetic: ATAC, D32, S8 |
GSM7829752 |
CD3+ depleted, epigenetic: ATAC, D44, S8 |
GSM7829753 |
CD3+ depleted, epigenetic: ATAC, D60, S8 |
GSM7829754 |
CD3+ depleted, epigenetic: ATAC, D0, S9 |
GSM7829755 |
CD3+ depleted, epigenetic: ATAC, D180, S9 |
GSM7829756 |
CD3+ depleted, epigenetic: ATAC, D32, S9 |
GSM7829757 |
CD3+ depleted, epigenetic: ATAC, D44, S9 |
GSM7829758 |
CD3+ depleted, epigenetic: ATAC, D0, S12 |
GSM7829759 |
CD3+ depleted, epigenetic: ATAC, D180, S12 |
GSM7829760 |
CD3+ depleted, epigenetic: ATAC, D32, S12 |
GSM7829761 |
CD3+ depleted, epigenetic: ATAC, D44, S12 |
GSM7829762 |
CD3+ depleted, epigenetic: ATAC, D60, S12 |
GSM7829763 |
CD3+ depleted, epigenetic: ATAC, D0, S14 |
GSM7829764 |
CD3+ depleted, epigenetic: ATAC, D180, S14 |
GSM7829765 |
CD3+ depleted, epigenetic: ATAC, D32, S14 |
GSM7829766 |
CD3+ depleted, epigenetic: ATAC, D44, S14 |
GSM7829767 |
CD3+ depleted, epigenetic: ATAC, D60, S14 |
GSM7829768 |
CD3+ depleted, epigenetic: ATAC, D0, S19 |
GSM7829769 |
CD3+ depleted, epigenetic: ATAC, D180, S19 |
GSM7829770 |
CD3+ depleted, epigenetic: ATAC, D32, S19 |
GSM7829771 |
CD3+ depleted, epigenetic: ATAC, D44, S19 |
|
This SubSeries is part of SuperSeries: |
GSE244795 |
AS01-adjuvanted vaccine promotes functional and epigenetic modifications in monocytes |
|
Relations |
BioProject |
PRJNA1024904 |
Supplementary file |
Size |
Download |
File type/resource |
GSE244792_RAW.tar |
1.7 Gb |
(http)(custom) |
TAR (of H5) |
Raw data are available in SRA |
|
|
|
|
|